The Market Reports

Index

1 DNA Repair Drugs Market Overview
1.1 Product Overview and Scope of DNA Repair Drugs
1.2 DNA Repair Drugs Segment by Type
1.2.1 Global DNA Repair Drugs Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 PARP Inhibitors
1.2.3 Other
1.3 DNA Repair Drugs Segment by Application
1.3.1 Global DNA Repair Drugs Sales Comparison by Application: (2021-2027)
1.3.2 Oncological
1.3.3 Stroke
1.4 Global DNA Repair Drugs Market Size Estimates and Forecasts
1.4.1 Global DNA Repair Drugs Revenue 2016-2027
1.4.2 Global DNA Repair Drugs Sales 2016-2027
1.4.3 DNA Repair Drugs Market Size by Region: 2016 Versus 2021 Versus 2027

2 DNA Repair Drugs Market Competition by Manufacturers
2.1 Global DNA Repair Drugs Sales Market Share by Manufacturers (2016-2021)
2.2 Global DNA Repair Drugs Revenue Market Share by Manufacturers (2016-2021)
2.3 Global DNA Repair Drugs Average Price by Manufacturers (2016-2021)
2.4 Manufacturers DNA Repair Drugs Manufacturing Sites, Area Served, Product Type
2.5 DNA Repair Drugs Market Competitive Situation and Trends
2.5.1 DNA Repair Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest DNA Repair Drugs Players Market Share by Revenue
2.5.3 Global DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 DNA Repair Drugs Retrospective Market Scenario by Region
3.1 Global DNA Repair Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global DNA Repair Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America DNA Repair Drugs Market Facts & Figures by Country
3.3.1 North America DNA Repair Drugs Sales by Country
3.3.2 North America DNA Repair Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe DNA Repair Drugs Market Facts & Figures by Country
3.4.1 Europe DNA Repair Drugs Sales by Country
3.4.2 Europe DNA Repair Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific DNA Repair Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific DNA Repair Drugs Sales by Region
3.5.2 Asia Pacific DNA Repair Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America DNA Repair Drugs Market Facts & Figures by Country
3.6.1 Latin America DNA Repair Drugs Sales by Country
3.6.2 Latin America DNA Repair Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa DNA Repair Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa DNA Repair Drugs Sales by Country
3.7.2 Middle East and Africa DNA Repair Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global DNA Repair Drugs Historic Market Analysis by Type
4.1 Global DNA Repair Drugs Sales Market Share by Type (2016-2021)
4.2 Global DNA Repair Drugs Revenue Market Share by Type (2016-2021)
4.3 Global DNA Repair Drugs Price by Type (2016-2021)

5 Global DNA Repair Drugs Historic Market Analysis by Application
5.1 Global DNA Repair Drugs Sales Market Share by Application (2016-2021)
5.2 Global DNA Repair Drugs Revenue Market Share by Application (2016-2021)
5.3 Global DNA Repair Drugs Price by Application (2016-2021)

6 Key Companies Profiled
6.1 4SC AG
6.1.1 4SC AG Corporation Information
6.1.2 4SC AG Description and Business Overview
6.1.3 4SC AG DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.1.4 4SC AG DNA Repair Drugs Product Portfolio
6.1.5 4SC AG Recent Developments/Updates
6.2 ARCAGY/ GINECO GROUP
6.2.1 ARCAGY/ GINECO GROUP Corporation Information
6.2.2 ARCAGY/ GINECO GROUP Description and Business Overview
6.2.3 ARCAGY/ GINECO GROUP DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.2.4 ARCAGY/ GINECO GROUP DNA Repair Drugs Product Portfolio
6.2.5 ARCAGY/ GINECO GROUP Recent Developments/Updates
6.3 Bristol Myers Squibb
6.3.1 Bristol Myers Squibb Corporation Information
6.3.2 Bristol Myers Squibb Description and Business Overview
6.3.3 Bristol Myers Squibb DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Bristol Myers Squibb DNA Repair Drugs Product Portfolio
6.3.5 Bristol Myers Squibb Recent Developments/Updates
6.4 British Columbia Cancer Agency
6.4.1 British Columbia Cancer Agency Corporation Information
6.4.2 British Columbia Cancer Agency Description and Business Overview
6.4.3 British Columbia Cancer Agency DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 British Columbia Cancer Agency DNA Repair Drugs Product Portfolio
6.4.5 British Columbia Cancer Agency Recent Developments/Updates
6.5 Cambridge University Hospitals NHS Foundation Trust
6.5.1 Cambridge University Hospitals NHS Foundation Trust Corporation Information
6.5.2 Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
6.5.3 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product Portfolio
6.5.5 Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
6.6 Genentech
6.6.1 Genentech Corporation Information
6.6.2 Genentech Description and Business Overview
6.6.3 Genentech DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Genentech DNA Repair Drugs Product Portfolio
6.6.5 Genentech Recent Developments/Updates
6.7 Georgetown University
6.6.1 Georgetown University Corporation Information
6.6.2 Georgetown University Description and Business Overview
6.6.3 Georgetown University DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Georgetown University DNA Repair Drugs Product Portfolio
6.7.5 Georgetown University Recent Developments/Updates
6.8 German Breast Group
6.8.1 German Breast Group Corporation Information
6.8.2 German Breast Group Description and Business Overview
6.8.3 German Breast Group DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.8.4 German Breast Group DNA Repair Drugs Product Portfolio
6.8.5 German Breast Group Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.9.4 GlaxoSmithKline DNA Repair Drugs Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Jiangsu Hengrui Medicine
6.10.1 Jiangsu Hengrui Medicine Corporation Information
6.10.2 Jiangsu Hengrui Medicine Description and Business Overview
6.10.3 Jiangsu Hengrui Medicine DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Jiangsu Hengrui Medicine DNA Repair Drugs Product Portfolio
6.10.5 Jiangsu Hengrui Medicine Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson DNA Repair Drugs Description and Business Overview
6.11.3 Johnson & Johnson DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Johnson & Johnson DNA Repair Drugs Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Jonsson Comprehensive Cancer Center
6.12.1 Jonsson Comprehensive Cancer Center Corporation Information
6.12.2 Jonsson Comprehensive Cancer Center DNA Repair Drugs Description and Business Overview
6.12.3 Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Jonsson Comprehensive Cancer Center DNA Repair Drugs Product Portfolio
6.12.5 Jonsson Comprehensive Cancer Center Recent Developments/Updates
6.13 Karyopharm Therapeutics
6.13.1 Karyopharm Therapeutics Corporation Information
6.13.2 Karyopharm Therapeutics DNA Repair Drugs Description and Business Overview
6.13.3 Karyopharm Therapeutics DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Karyopharm Therapeutics DNA Repair Drugs Product Portfolio
6.13.5 Karyopharm Therapeutics Recent Developments/Updates
6.14 KuDOS Pharmaceuticals
6.14.1 KuDOS Pharmaceuticals Corporation Information
6.14.2 KuDOS Pharmaceuticals DNA Repair Drugs Description and Business Overview
6.14.3 KuDOS Pharmaceuticals DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.14.4 KuDOS Pharmaceuticals DNA Repair Drugs Product Portfolio
6.14.5 KuDOS Pharmaceuticals Recent Developments/Updates
6.15 National Health Service
6.15.1 National Health Service Corporation Information
6.15.2 National Health Service DNA Repair Drugs Description and Business Overview
6.15.3 National Health Service DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.15.4 National Health Service DNA Repair Drugs Product Portfolio
6.15.5 National Health Service Recent Developments/Updates
6.16 National Institutes of Health
6.16.1 National Institutes of Health Corporation Information
6.16.2 National Institutes of Health DNA Repair Drugs Description and Business Overview
6.16.3 National Institutes of Health DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.16.4 National Institutes of Health DNA Repair Drugs Product Portfolio
6.16.5 National Institutes of Health Recent Developments/Updates
6.17 Tesaro
6.17.1 Tesaro Corporation Information
6.17.2 Tesaro DNA Repair Drugs Description and Business Overview
6.17.3 Tesaro DNA Repair Drugs Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Tesaro DNA Repair Drugs Product Portfolio
6.17.5 Tesaro Recent Developments/Updates

7 DNA Repair Drugs Manufacturing Cost Analysis
7.1 DNA Repair Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of DNA Repair Drugs
7.4 DNA Repair Drugs Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 DNA Repair Drugs Distributors List
8.3 DNA Repair Drugs Customers

9 DNA Repair Drugs Market Dynamics
9.1 DNA Repair Drugs Industry Trends
9.2 DNA Repair Drugs Growth Drivers
9.3 DNA Repair Drugs Market Challenges
9.4 DNA Repair Drugs Market Restraints

10 Global Market Forecast
10.1 DNA Repair Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of DNA Repair Drugs by Type (2022-2027)
10.1.2 Global Forecasted Revenue of DNA Repair Drugs by Type (2022-2027)
10.2 DNA Repair Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of DNA Repair Drugs by Application (2022-2027)
10.2.2 Global Forecasted Revenue of DNA Repair Drugs by Application (2022-2027)
10.3 DNA Repair Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of DNA Repair Drugs by Region (2022-2027)
10.3.2 Global Forecasted Revenue of DNA Repair Drugs by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global DNA Repair Drugs Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global DNA Repair Drugs Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global DNA Repair Drugs Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers DNA Repair Drugs Covered in This Study
Table 5. Global DNA Repair Drugs Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global DNA Repair Drugs Sales Market Share by Manufacturers (2016-2021)
Table 7. Global DNA Repair Drugs Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global DNA Repair Drugs Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market DNA Repair Drugs Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers DNA Repair Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers DNA Repair Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global DNA Repair Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in DNA Repair Drugs as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global DNA Repair Drugs Sales by Region (2016-2021) & (K Units)
Table 16. Global DNA Repair Drugs Sales Market Share by Region (2016-2021)
Table 17. Global DNA Repair Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America DNA Repair Drugs Sales by Country (2016-2021) & (K Units)
Table 19. North America DNA Repair Drugs Sales Market Share by Country (2016-2021)
Table 20. North America DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America DNA Repair Drugs Revenue Market Share by Country (2016-2021)
Table 22. Europe DNA Repair Drugs Sales by Country (2016-2021) & (K Units)
Table 23. Europe DNA Repair Drugs Sales Market Share by Country (2016-2021)
Table 24. Europe DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe DNA Repair Drugs Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific DNA Repair Drugs Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific DNA Repair Drugs Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific DNA Repair Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific DNA Repair Drugs Revenue Market Share by Region (2016-2021)
Table 30. Latin America DNA Repair Drugs Sales by Country (2016-2021) & (K Units)
Table 31. Latin America DNA Repair Drugs Sales Market Share by Country (2016-2021)
Table 32. Latin America DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America DNA Repair Drugs Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa DNA Repair Drugs Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa DNA Repair Drugs Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa DNA Repair Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa DNA Repair Drugs Revenue Market Share by Country (2016-2021)
Table 38. Global DNA Repair Drugs Sales (K Units) by Type (2016-2021)
Table 39. Global DNA Repair Drugs Sales Market Share by Type (2016-2021)
Table 40. Global DNA Repair Drugs Revenue (Million US$) by Type (2016-2021)
Table 41. Global DNA Repair Drugs Revenue Share by Type (2016-2021)
Table 42. Global DNA Repair Drugs Price (USD/Unit) by Type (2016-2021)
Table 43. Global DNA Repair Drugs Sales (K Units) by Application (2016-2021)
Table 44. Global DNA Repair Drugs Sales Market Share by Application (2016-2021)
Table 45. Global DNA Repair Drugs Revenue (Million US$) by Application (2016-2021)
Table 46. Global DNA Repair Drugs Revenue Share by Application (2016-2021)
Table 47. Global DNA Repair Drugs Price (USD/Unit) by Application (2016-2021)
Table 48. 4SC AG Corporation Information
Table 49. 4SC AG Description and Business Overview
Table 50. 4SC AG DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. 4SC AG DNA Repair Drugs Product
Table 52. 4SC AG Recent Developments/Updates
Table 53. ARCAGY/ GINECO GROUP Corporation Information
Table 54. ARCAGY/ GINECO GROUP Description and Business Overview
Table 55. ARCAGY/ GINECO GROUP DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. ARCAGY/ GINECO GROUP DNA Repair Drugs Product
Table 57. ARCAGY/ GINECO GROUP Recent Developments/Updates
Table 58. Bristol Myers Squibb Corporation Information
Table 59. Bristol Myers Squibb Description and Business Overview
Table 60. Bristol Myers Squibb DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Bristol Myers Squibb DNA Repair Drugs Product
Table 62. Bristol Myers Squibb Recent Developments/Updates
Table 63. British Columbia Cancer Agency Corporation Information
Table 64. British Columbia Cancer Agency Description and Business Overview
Table 65. British Columbia Cancer Agency DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. British Columbia Cancer Agency DNA Repair Drugs Product
Table 67. British Columbia Cancer Agency Recent Developments/Updates
Table 68. Cambridge University Hospitals NHS Foundation Trust Corporation Information
Table 69. Cambridge University Hospitals NHS Foundation Trust Description and Business Overview
Table 70. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Cambridge University Hospitals NHS Foundation Trust DNA Repair Drugs Product
Table 72. Cambridge University Hospitals NHS Foundation Trust Recent Developments/Updates
Table 73. Genentech Corporation Information
Table 74. Genentech Description and Business Overview
Table 75. Genentech DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Genentech DNA Repair Drugs Product
Table 77. Genentech Recent Developments/Updates
Table 78. Georgetown University Corporation Information
Table 79. Georgetown University Description and Business Overview
Table 80. Georgetown University DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Georgetown University DNA Repair Drugs Product
Table 82. Georgetown University Recent Developments/Updates
Table 83. German Breast Group Corporation Information
Table 84. German Breast Group Description and Business Overview
Table 85. German Breast Group DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. German Breast Group DNA Repair Drugs Product
Table 87. German Breast Group Recent Developments/Updates
Table 88. GlaxoSmithKline Corporation Information
Table 89. GlaxoSmithKline Description and Business Overview
Table 90. GlaxoSmithKline DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. GlaxoSmithKline DNA Repair Drugs Product
Table 92. GlaxoSmithKline Recent Developments/Updates
Table 93. Jiangsu Hengrui Medicine Corporation Information
Table 94. Jiangsu Hengrui Medicine Description and Business Overview
Table 95. Jiangsu Hengrui Medicine DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Jiangsu Hengrui Medicine DNA Repair Drugs Product
Table 97. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Business Overview
Table 100. Johnson & Johnson DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Johnson & Johnson DNA Repair Drugs Product
Table 102. Johnson & Johnson Recent Developments/Updates
Table 103. Jonsson Comprehensive Cancer Center Corporation Information
Table 104. Jonsson Comprehensive Cancer Center Description and Business Overview
Table 105. Jonsson Comprehensive Cancer Center DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Jonsson Comprehensive Cancer Center DNA Repair Drugs Product
Table 107. Jonsson Comprehensive Cancer Center Recent Developments/Updates
Table 108. Karyopharm Therapeutics Corporation Information
Table 109. Karyopharm Therapeutics Description and Business Overview
Table 110. Karyopharm Therapeutics DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Karyopharm Therapeutics DNA Repair Drugs Product
Table 112. Karyopharm Therapeutics Recent Developments/Updates
Table 113. KuDOS Pharmaceuticals Corporation Information
Table 114. KuDOS Pharmaceuticals Description and Business Overview
Table 115. KuDOS Pharmaceuticals DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. KuDOS Pharmaceuticals DNA Repair Drugs Product
Table 117. KuDOS Pharmaceuticals Recent Developments/Updates
Table 118. National Health Service Corporation Information
Table 119. National Health Service Description and Business Overview
Table 120. National Health Service DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. National Health Service DNA Repair Drugs Product
Table 122. National Health Service Recent Developments/Updates
Table 123. National Institutes of Health Corporation Information
Table 124. National Institutes of Health Description and Business Overview
Table 125. National Institutes of Health DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. National Institutes of Health DNA Repair Drugs Product
Table 127. National Institutes of Health Recent Developments/Updates
Table 128. Tesaro Corporation Information
Table 129. Tesaro Description and Business Overview
Table 130. Tesaro DNA Repair Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Tesaro DNA Repair Drugs Product
Table 132. Tesaro Recent Developments/Updates
Table 133. Production Base and Market Concentration Rate of Raw Material
Table 134. Key Suppliers of Raw Materials
Table 135. DNA Repair Drugs Distributors List
Table 136. DNA Repair Drugs Customers List
Table 137. DNA Repair Drugs Market Trends
Table 138. DNA Repair Drugs Growth Drivers
Table 139. DNA Repair Drugs Market Challenges
Table 140. DNA Repair Drugs Market Restraints
Table 141. Global DNA Repair Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 142. Global DNA Repair Drugs Sales Market Share Forecast by Type (2022-2027)
Table 143. Global DNA Repair Drugs Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 144. Global DNA Repair Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 145. Global DNA Repair Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 146. Global DNA Repair Drugs Sales Market Share Forecast by Application (2022-2027)
Table 147. Global DNA Repair Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 148. Global DNA Repair Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 149. Global DNA Repair Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 150. Global DNA Repair Drugs Sales Market Share Forecast by Region (2022-2027)
Table 151. Global DNA Repair Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 152. Global DNA Repair Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DNA Repair Drugs
Figure 2. Global DNA Repair Drugs Market Share by Type in 2020 & 2027
Figure 3. PARP Inhibitors Product Picture
Figure 4. Other Product Picture
Figure 5. Global DNA Repair Drugs Market Share by Application in 2020 & 2027
Figure 6. Oncological
Figure 7. Stroke
Figure 8. Global DNA Repair Drugs Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global DNA Repair Drugs Market Size 2016-2027 (US$ Million)
Figure 10. Global DNA Repair Drugs Sales 2016-2027 (K Units)
Figure 11. Global DNA Repair Drugs Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. DNA Repair Drugs Sales Share by Manufacturers in 2020
Figure 13. Global DNA Repair Drugs Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest DNA Repair Drugs Players: Market Share by Revenue in 2020
Figure 15. DNA Repair Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global DNA Repair Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global DNA Repair Drugs Sales Market Share by Region in 2020
Figure 18. Global DNA Repair Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global DNA Repair Drugs Revenue Market Share by Region in 2020
Figure 20. U.S. DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E DNA Repair Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of DNA Repair Drugs by Type (2016-2021)
Figure 45. Sales Market Share of DNA Repair Drugs by Application (2016-2021)
Figure 46. Sales Market Share of DNA Repair Drugs by Application in 2020
Figure 47. Revenue Share of DNA Repair Drugs by Application (2016-2021)
Figure 48. Revenue Share of DNA Repair Drugs by Application in 2020
Figure 49. Manufacturing Cost Structure of DNA Repair Drugs
Figure 50. Manufacturing Process Analysis of DNA Repair Drugs
Figure 51. DNA Repair Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed